$ONVO
ORGANOVO HOLDINGS, INC.

2014 Q4 Form 10-Q Financial Statement

#000119312514403624 Filed on November 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $155.0K $50.00K $23.00K
YoY Change 14.81% 117.39% -95.1%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.878M $5.777M $4.003M
YoY Change 63.01% 44.32% 34.28%
% of Gross Profit
Research & Development $3.240M $3.229M $1.622M
YoY Change 37.35% 99.08% 46.65%
% of Gross Profit
Depreciation & Amortization $120.0K $110.0K $100.0K
YoY Change 20.0% 10.0% 25.0%
% of Gross Profit
Operating Expenses $3.878M $9.006M $5.625M
YoY Change -18.15% 60.11% 37.63%
Operating Profit -$6.961M -$8.956M -$5.602M
YoY Change 50.48% 59.87% 54.84%
Interest Expense -$30.00K $100.0K -$4.780M
YoY Change -94.83% -102.09% -111.31%
% of Operating Profit
Other Income/Expense, Net -$32.00K $98.00K -$4.784M
YoY Change -94.5% -102.05% -111.36%
Pretax Income -$6.990M -$8.860M -$10.39M
YoY Change 34.17% -14.73% -127.0%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.993M -$8.858M -$10.39M
YoY Change 34.27% -14.71% -126.99%
Net Earnings / Revenue -4511.61% -17716.0% -45156.52%
Basic Earnings Per Share -$0.14
Diluted Earnings Per Share -$1.739M -$2.243M -$0.14
COMMON SHARES
Basic Shares Outstanding 80.50M shares 78.48M shares 72.72M shares
Diluted Shares Outstanding 72.72M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.03M $54.39M $53.36M
YoY Change 0.42% 1.93% 594.79%
Cash & Equivalents $50.03M $54.39M $53.36M
Short-Term Investments
Other Short-Term Assets $370.0K $620.0K $300.0K
YoY Change -40.32% 106.67% 114.29%
Inventory $69.00K $70.00K $74.00K
Prepaid Expenses
Receivables $30.00K
Other Receivables $0.00
Total Short-Term Assets $50.47M $55.11M $53.74M
YoY Change -0.12% 2.55% 552.92%
LONG-TERM ASSETS
Property, Plant & Equipment $1.440M $1.273M $1.031M
YoY Change 57.38% 23.47% 69.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $83.00K $85.00K $94.00K
YoY Change -9.78% -9.57% -55.24%
Total Long-Term Assets $1.602M $1.437M $1.163M
YoY Change 47.51% 23.56% 43.58%
TOTAL ASSETS
Total Short-Term Assets $50.47M $55.11M $53.74M
Total Long-Term Assets $1.602M $1.437M $1.163M
Total Assets $52.07M $56.54M $54.90M
YoY Change 0.88% 2.99% 507.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $495.0K $530.0K $477.0K
YoY Change 59.16% 11.11% 695.0%
Accrued Expenses $2.028M $1.559M $1.583M
YoY Change 30.08% -1.52% 90.72%
Deferred Revenue
YoY Change
Short-Term Debt $300.0K $0.00 $0.00
YoY Change
Long-Term Debt Due $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $3.716M $3.112M $2.940M
YoY Change 28.09% 5.85% 200.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% -50.0%
Other Long-Term Liabilities $40.00K $0.00 $10.00K
YoY Change 300.0% -100.0% -99.97%
Total Long-Term Liabilities $40.00K $0.00 $20.00K
YoY Change 100.0% -100.0% -99.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.716M $3.112M $2.940M
Total Long-Term Liabilities $40.00K $0.00 $20.00K
Total Liabilities $3.760M $3.114M $2.956M
YoY Change 29.03% 5.35% -91.89%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $162.8M $80.00K $77.00K
YoY Change 211337.66% 3.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $48.31M $53.43M $51.94M
YoY Change
Total Liabilities & Shareholders Equity $52.07M $56.54M $54.90M
YoY Change 0.88% 2.99% 507.28%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$6.993M -$8.858M -$10.39M
YoY Change 34.27% -14.71% -126.99%
Depreciation, Depletion And Amortization $120.0K $110.0K $100.0K
YoY Change 20.0% 10.0% 25.0%
Cash From Operating Activities -$4.310M -$6.310M -$3.600M
YoY Change 10.51% 75.28% 56.52%
INVESTING ACTIVITIES
Capital Expenditures -$290.0K -$340.0K -$20.00K
YoY Change -1550.0% 1600.0% -88.89%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$290.0K -$340.0K -$20.00K
YoY Change 1350.0% 1600.0% -88.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $43.40M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 240.0K 16.15M 44.11M
YoY Change -38.46% -63.39% 2525.6%
NET CHANGE
Cash From Operating Activities -4.310M -6.310M -3.600M
Cash From Investing Activities -290.0K -340.0K -20.00K
Cash From Financing Activities 240.0K 16.15M 44.11M
Net Change In Cash -4.360M 9.500M 40.49M
YoY Change 23.51% -76.54% -5225.32%
FREE CASH FLOW
Cash From Operating Activities -$4.310M -$6.310M -$3.600M
Capital Expenditures -$290.0K -$340.0K -$20.00K
Free Cash Flow -$4.020M -$5.970M -$3.580M
YoY Change 2.55% 66.76% 68.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2035057 shares
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53357000
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
75000 shares
CY2013Q4 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03 pure
CY2013Q4 onvo Increased Office Space Headquarters
IncreasedOfficeSpaceHeadquarters
15268 sqft
CY2013Q4 onvo Additional Leased Office Space
AdditionalLeasedOfficeSpace
15539 sqft
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80404648 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2349427 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1559000
CY2013Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
4.50
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
80504648 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
650000 shares
CY2014Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8647 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80404648 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
377245 shares
CY2014Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11307649 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03 pure
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.14
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6381872 shares
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.95
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
10000
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Next Rolling Twelve Months
OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths
444000
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
160852000
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
6966000
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
530000
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3112000
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2527000
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
984000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.87
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5935888 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
822000
CY2014Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
10000
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
140419000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
326000
CY2014Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
258000
CY2014Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
1000
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
53428000
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive
1031000
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Four
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour
1001000
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Two
OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo
979000
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
140000
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
80000
CY2014Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
615000
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56542000
CY2014Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
31000
CY2014Q3 us-gaap Liabilities
Liabilities
3114000
CY2014Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1000
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q3 us-gaap Assets Current
AssetsCurrent
55105000
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
85000
CY2014Q3 us-gaap Assets
Assets
56542000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54389000
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
30000
CY2014Q3 us-gaap Inventory Net
InventoryNet
70000
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8414477
CY2014Q3 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
107504000
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
616000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
14989496
CY2014Q3 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
79000
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
15400000
CY2014Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
70000
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1273000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15628000
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78113639 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78113639 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
573495 shares
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1893000
CY2014Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
377000
CY2014Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
5000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
48284000
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13000
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
78000
CY2014Q1 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
345000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50186000
CY2014Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
31000
CY2014Q1 us-gaap Liabilities
Liabilities
1902000
CY2014Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4000
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Assets Current
AssetsCurrent
49161000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
89000
CY2014Q1 us-gaap Assets
Assets
50186000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48167000
CY2014Q1 us-gaap Inventory Net
InventoryNet
63000
CY2014Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
92213000
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
931000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20482823
CY2014Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
79000
CY2014Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
63000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
857000
CY2013Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2016-08-01
CY2013Q4 onvo Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
38800
CY2013Q4 onvo Additional Office Space
AdditionalOfficeSpace
14500 sqft
CY2013Q4 onvo Operating Leases Monthly Rent Expense
OperatingLeasesMonthlyRentExpense
38934
CY2013Q4 onvo Office Space Area Under Lease Agreement
OfficeSpaceAreaUnderLeaseAgreement
30807 sqft
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0084 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.848 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68776718 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6256000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7300 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6900000 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7300 shares
us-gaap Revenues
Revenues
129000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
49000
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Investment Income Interest
InvestmentIncomeInterest
7000
us-gaap Profit Loss
ProfitLoss
-14157000
us-gaap Revenue From Grants
RevenueFromGrants
12000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9336000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4000
us-gaap Interest Paid
InterestPaid
0
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
5000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4821000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14000
us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
176000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4811000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
44111000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
19000
us-gaap Share Based Compensation
ShareBasedCompensation
2088000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
37729000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-126000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
833000
us-gaap Interest Expense
InterestExpense
13000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-164000
us-gaap Cost Of Services Amortization
CostOfServicesAmortization
72000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3104000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
190000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
210000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6361000
onvo Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-30000
onvo Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
2278557 shares
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
44096000
onvo Deduction In Warrant Liability
DeductionInWarrantLiability
10147000
onvo Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-101000
onvo Payment For Expense On Warrant Modification
PaymentForExpenseOnWarrantModification
12000
onvo Revenue From Research Collaborations
RevenueFromResearchCollaborations
117000
onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
1870986 shares
onvo Warrant Reclassified Equity Instruments
WarrantReclassifiedEquityInstruments
767000
onvo Increase Decrease In Cash Deposits Released From Restriction
IncreaseDecreaseInCashDepositsReleasedFromRestriction
50000
onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
1817928 shares
dei Trading Symbol
TradingSymbol
ONVO
dei Entity Registrant Name
EntityRegistrantName
ORGANOVO HOLDINGS, INC.
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001497253
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
us-gaap Revenue Recognition Multiple Element Arrangements
RevenueRecognitionMultipleElementArrangements
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> Revenue Arrangements with Multiple Deliverables</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The Company occasionally enters into revenue arrangements that contain multiple deliverables. Judgment is required to properly identify the accounting units of the multiple deliverable transactions and to determine the manner in which revenue should be allocated among the accounting units. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria of revenue recognition have been met for each deliverable in order for revenue recognition to occur in the appropriate accounting period. For multiple deliverable agreements, consideration is allocated at the inception of the agreement to all deliverables based on their relative selling price. The relative selling price for each deliverable is determined using vendor-specific objective evidence (&#x201C;VSOE&#x201D;) of selling price or third-party evidence of selling price if VSOE does not exist. If neither VSOE nor third-party evidence of selling price exists, the Company uses its best estimate of the selling price for the deliverable.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The Company recognizes revenue for delivered elements only when it determines there are no uncertainties regarding customer acceptance. While changes in the allocation of the arrangement consideration between the units of accounting will not affect the amount of total revenue recognized for a particular sales arrangement, any material changes in these allocations could impact the timing of revenue recognition, which could affect the Company&#x2019;s results of operations.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The Company expects to periodically receive license fees for non-exclusive research licensing associated with funded research projects. License fees under these arrangements are recognized over the term of the contract or development period as it has been determined that such licenses do not have stand-alone value.</p> </div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0161 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
200000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.771 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78589521 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.53
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9677000
us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
The estimated useful lives of the fixed assets range between two and seven years.
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y26D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
88746 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.06
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9700000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.12
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
556855 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
22125 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <i>Reclassifications</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Certain reclassifications were made to the Condensed Consolidated Balance Sheet as of March&#xA0;31, 2014 and the Condensed Consolidated Statement of Operations for the three and six months ended September&#xA0;30, 2013 in order to conform to the presentation of the Condensed Consolidated Balance Sheet as of September&#xA0;30, 2014 and the Condensed Consolidated Statement of Operations for the three and six months ended September&#xA0;30, 2014. The reclassifications did not have any effect on previously reported net loss or financial position.</p> </div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.22
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7900000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> <i>Use of estimates</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates used in preparing the condensed consolidated financial statements include those assumed in computing the valuation of warrants, revenue recognized under the proportional performance model, the valuation of stock-based compensation expense, and the valuation allowance on deferred tax assets.</p> </div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
196250 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
88746 shares
us-gaap Revenues
Revenues
149000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-113000
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Investment Income Interest
InvestmentIncomeInterest
14000
us-gaap Profit Loss
ProfitLoss
-15291000
us-gaap Revenue From Grants
RevenueFromGrants
35000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15366000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3000
us-gaap Interest Paid
InterestPaid
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
4000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
75000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7000
us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
576000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-64000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
16475000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
124000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
425156
us-gaap Share Based Compensation
ShareBasedCompensation
3634000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6222000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-576000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
737000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
204000
us-gaap Cost Of Services Amortization
CostOfServicesAmortization
469000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6043000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
188000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
208000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
470000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9472000
onvo Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
223000
onvo Lease Amendment Effective Date
LeaseAmendmentEffectiveDate
2014-09-01
onvo Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
111647 shares
onvo Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
38800
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
16291000
onvo Common Stock Warrants Issued
CommonStockWarrantsIssued
50000 shares
onvo Leasehold Improvements Funded By Lease Incentive
LeaseholdImprovementsFundedByLeaseIncentive
47000
onvo Deduction In Warrant Liability
DeductionInWarrantLiability
55000
onvo Lease Term With Option To Extend
LeaseTermWithOptionToExtend
P48M
onvo Revenue From Research Collaborations
RevenueFromResearchCollaborations
114000
onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
110600 shares
onvo Warrant Or Right Expense Or Revenue Recognized
WarrantOrRightExpenseOrRevenueRecognized
202000
onvo Warrant Reclassified Equity Instruments
WarrantReclassifiedEquityInstruments
0
onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
8647 shares
CY2013Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
43400000
CY2013Q3 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
3200000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0060 pure
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9690 pure
CY2013Q4 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2013Q4 onvo Warrant Earning Period Through Issuance Of Common Stock
WarrantEarningPeriodThroughIssuanceOfCommonStock
P12M
CY2011 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2012 onvo Number Of Agreement With Consultants For Services
NumberOfAgreementWithConsultantsForServices
4 Agreement
CY2012 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0063 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.826 pure
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72716031 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.00
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2013Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7300 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6900000 shares
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7300 shares
CY2013Q3 us-gaap Revenues
Revenues
23000
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000
CY2013Q3 us-gaap Profit Loss
ProfitLoss
-10386000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5602000
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4784000
CY2013Q3 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2013Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4787000
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1622000
CY2013Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
105000
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4003000
CY2013Q3 onvo Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
2026428 shares
CY2013Q3 onvo Revenue From Research Collaborations
RevenueFromResearchCollaborations
23000
CY2013Q3 onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
1670851 shares
CY2013Q3 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
1782928 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0166 pure
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.763 pure
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78933884 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.16
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2014Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
28224 shares
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7900000 shares
CY2014Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
28224 shares
CY2014Q3 us-gaap Revenues
Revenues
50000
CY2014Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000
CY2014Q3 us-gaap Profit Loss
ProfitLoss
-8858000
CY2014Q3 us-gaap Revenue From Grants
RevenueFromGrants
5000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8956000
CY2014Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3000
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
98000
CY2014Q3 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2014Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-94000
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3229000
CY2014Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
235000
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5777000
CY2014Q3 onvo Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
0 shares
CY2014Q3 onvo Revenue From Research Collaborations
RevenueFromResearchCollaborations
45000
CY2014Q3 onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
0 shares
CY2014Q3 onvo Warrant Or Right Expense Or Revenue Recognized
WarrantOrRightExpenseOrRevenueRecognized
101000
CY2014Q3 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
0 shares

Files In Submission

Name View Source Status
0001193125-14-403624-index-headers.html Edgar Link pending
0001193125-14-403624-index.html Edgar Link pending
0001193125-14-403624.txt Edgar Link pending
0001193125-14-403624-xbrl.zip Edgar Link pending
d783858d10q.htm Edgar Link pending
d783858dex311.htm Edgar Link pending
d783858dex312.htm Edgar Link pending
d783858dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
onvo-20140930.xml Edgar Link completed
onvo-20140930.xsd Edgar Link pending
onvo-20140930_cal.xml Edgar Link unprocessable
onvo-20140930_def.xml Edgar Link unprocessable
onvo-20140930_lab.xml Edgar Link unprocessable
onvo-20140930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending